%0 Journal Article %T 基于双硫死亡相关lncRNA的骨肉瘤预后模型构建及验证
Construction and Validation of a Prognostic Model for Osteosarcoma Based on Disulfide Death Related lncRNA %A 高艳芳 %A 李恩惠 %J Advances in Clinical Medicine %P 1485-1498 %@ 2161-8720 %D 2024 %I Hans Publishing %R 10.12677/acm.2024.14102823 %X 目的:探索双硫死亡相关lncRNAs (DRLs)在骨肉瘤(Osteosarcoma, OS)患者中的预后价值。方法:从TCGA数据库中提取OS患者的基因表达和相关临床数据,筛选预后相关DRLs基因,构建预后模型并进行验证。qRT-PCR分析检测相关DRLs在细胞及组织中的表达。CCK-8实验检测si-ASB16.AS1对MG-63细胞增殖能力的影响。采用Kaplan-Meier法绘制生存曲线,Cox回归用于分析影响骨肉瘤患者预后的因素。结果:筛选出6个预后相关DRLs (RP11.304F15.6、RP11.750H9.5、RP11.313F23.4、RP11.46C2.47、ASB16.AS1和RP11.452C13.1)用于构建预后模型。ROC分析表明,该模型具有较强的预测能力。qRT-PCR分析表明6个DRLs在OS细胞系中表达上调,si-ASB16.AS1可抑制MG-63细胞增殖。并且,ASB16.AS1在OS患者癌组织中的表达也是上调的,ASB16.AS1高表达的OS患者总体生存时间显著短于低表达患者,ASB16.AS1是OS患者一个独立的预后生物标志物。结论:本研究确定了6个DRLs作为OS预后的标志,构建了一个有价值的OS预后模型;并发现ASB16.AS1可参与OS细胞的增殖,是OS患者一个独立的预后生物标志物。
Objective: To explore the prognostic value of disulfide death related lncRNAs (DRLs) in patients with osteosarcoma (OS). Methods: The gene expression and related clinical data of OS patients were extracted from TCGA database, and prognostic related DRLs genes were screened to construct a prognostic model. The expression of related DRLs in cells and tissues was detected by qRT-PCR. The effect of si-ASB16.AS1 on the proliferation of MG-63 cells was detected by CCK-8 assay. Kaplan-Meier method was used to draw the survival curve, and Cox regression was used to analyze the factors affecting the prognosis of patients with OS. Results: Six prognostic related DRLs (RP11.304F15.6, RP11.750H9.5, RP11.313F23.4, RP11.46C2.47, ASB16.AS1, and RP11.452C13.1) were selected for constructing a prognostic model. ROC analysis showed that the model had a strong predictive ability. qRT-PCR analysis showed that the expression of six DRLs was up-regulated in OS cell lines, and si-ASB16.AS1 inhibited the proliferation of MG-63 cells. The overall survival time of OS patients with high ASB16.AS1 expression is significantly shorter than that of patients with low ASB16.AS1 expression. Conclusion: 6 DRLs were identified as prognostic markers of OS, and a valuable prognostic model of OS was constructed. It was found that ASB16.AS1 can participate in the proliferation of OS cells and is an independent prognostic biomarker in patients with OS. %K 双硫死亡, %K 骨肉瘤, %K lncRNAs, %K qRT-PCR, %K 增殖, %K 预后
Double Sulfur Death %K Osteosarcoma %K lncRNAs %K qRT-PCR %K Proliferation %K Prognosis %U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=98981